Friday, March 19, 2021
9:00 – 10:00 am ET

The First and Only Non-Scheduled Treatment for Excessive Daytime Sleepiness (EDS) or Cataplexy in Adult Patients With Narcolepsy

Join us for a discussion about a first-in-class treatment for adult patients with narcolepsy.

• Pathophysiology of narcolepsy and presentation of EDS and cataplexy in narcolepsy
• WAKIX® (pitolisant) mechanism of action
• WAKIX efficacy and safety in clinical trials
• WAKIX dosing and administration
• Prescribing WAKIX

Attendee Log On Information

When it’s time, join the meeting from here using the information below:

Access Information
• Meeting ID: HAR2021-001833
• Meeting password: 109a9

Dial-In Information
• +1-415-655-0002 TOLL US
• +1-855-797-9485 TOLL-FREE
• Access Code: 160 419 8844

T.J. White

Special Territory Manager


Nico D'Angelo

Special Territory Manager